Abstract: An electronic device comprising a switchable mirror operating in a transparent mode or a mirror mode; a display to be arranged such that at least a portion of the display faces one surface of the switchable mirror; and at least one processor while connected to the switchable mirror and the display obtains information about the operating mode of the electronic device, and controls, based on the obtained information, the operating mode of the electronic device to be in in any one of a first mode in which the switchable mirror is in the transparent mode and the display is turned on, a second mode in which the switchable mirror is in the mirror mode and the display is turned on, and a third mode in which the switchable mirror is in the mirror mode and the display is turned off.

Abstract: Provided is an electronic device including a first sensor configured to sense a user; a second sensor configured to sense light incident from an external light source; a mirror display; a memory; and a processor configured to: based on the first sensor sensing the user in front of the mirror display, obtain information about a first area in which a first image corresponding to a reflection of the user is located on the mirror display; determine a second area for displaying content to be provided to the user based on the information about the first area; based on information about light being obtained through the second sensor, determine luminance of the second area based on the information about the light; and control the mirror display to display the content with the determined luminance on the second area.

Abstract: Provided is a display device including: a display; memory storing one or more instructions; and at least one processor configured to execute the one or more instructions stored in the memory, wherein the one or more instructions, when executed by the at least one processor, cause the display device to: recognize a display ratio of content, generate, based on the recognized display ratio of the content and a display ratio of the display, a first area of an image of the content to be displayed on the display, and a second area of the image of the content to be displayed by an external device on a surrounding area of the display, transmit the second area to the external device, and display the first area on the display while causing the external device to display the second area on the surrounding area of the display.

Abstract: Provided is a computer-implemented method, including inputting to a trained machine learning classifier genomic information of a non-training subject that includes features from a tumor sample, wherein the trained machine learning classifier trained on features of tumor samples obtained from training subjects and their a responsiveness to checkpoint inhibition treatment and the machine-learning classifier is trained to predict responsiveness to the treatment, and generating a checkpoint inhibition responsiveness classification predictive of the subject's responding to the checkpoint inhibition with the trained machine-learning classifier, and reporting the checkpoint inhibition responsiveness classification using a graphical user interface. Also provided are a computer system for performing the method and a machine learning classifier trained by the method.

Abstract: An electronic apparatus, includes: one or more processors; and at least one memory storing instructions that, when executed by the one or more processors, cause the electronic apparatus to: obtain image frames in a user-captured image stored in the at least one memory; identify an object which includes motion information based on the image frames; obtain first feature information of the object from a first image frame from among the image frames; obtain a first avatar image corresponding to the object based on the first feature information; obtain second feature information of the object from a second image frame from among the image frames; obtain a second avatar image corresponding to the object based on the second feature information; and obtain a virtual space image based on the first avatar image and the second avatar image.

Abstract: Provided is an electronic device including a first sensor configured to sense a user; a second sensor configured to sense light incident from an external light source; a mirror display; a memory; and a processor configured to: based on the first sensor sensing the user in front of the mirror display, obtain information about a first area in which a first image corresponding to a reflection of the user is located on the mirror display; determine a second area for displaying content to be provided to the user based on the information about the first area; based on information about light being obtained through the second sensor, determine luminance of the second area based on the information about the light; and control the mirror display to display the content with the determined luminance on the second area.

Abstract: Provided is an electronic device including a first sensor configured to sense a user; a second sensor configured to sense light incident from an external light source; a mirror display; a memory; and a processor configured to: based on the first sensor sensing the user in front of the mirror display, obtain information about a first area in which a first image corresponding to a reflection of the user is located on the mirror display; determine a second area for displaying content to be provided to the user based on the information about the first area; based on information about light being obtained through the second sensor, determine luminance of the second area based on the information about the light; and control the mirror display to display the content with the determined luminance on the second area.

Abstract: Provided is a computer-implemented method, including inputting to a trained machine learning classifier genomic information of a non-training subject that includes features from a tumor sample, wherein the trained machine learning classifier trained on features of tumor samples obtained from training subjects and their a responsiveness to checkpoint inhibition treatment and the machine-learning classifier is trained to predict responsiveness to the treatment, and generating a checkpoint inhibition responsiveness classification predictive of the subject's responding to the checkpoint inhibition with the trained machine-learning classifier, and reporting the checkpoint inhibition responsiveness classification using a graphical user interface. Also provided are a computer system for performing the method and a machine learning classifier trained by the method.

Abstract: Provided is an electronic device including a first sensor configured to sense a user; a second sensor configured to sense light incident from an external light source; a mirror display; a memory; and a processor configured to: based on the first sensor sensing the user in front of the mirror display, obtain information about a first area in which a first image corresponding to a reflection of the user is located on the mirror display; determine a second area for displaying content to be provided to the user based on the information about the first area; based on information about light being obtained through the second sensor, determine luminance of the second area based on the information about the light; and control the mirror display to display the content with the determined luminance on the second area.

Abstract: The present invention relates to a pharmaceutical preparation containing an active ingredient and a release-controlling agent for adjusting the release of the active ingredient, in which the active ingredient is at least one selected from among mirabegron and a pharmaceutically acceptable salt thereof, and the release-controlling agent is a hydrogel-forming polymer, the hydrogel-forming polymer being at least one selected from among polyethylene oxide, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, sodium carboxymethylcellulose, and hydroxyethyl cellulose and having an average molecular weight ranging from 100,000 to 8,000,000. The present invention is capable of suppressing the generation of impurities therein and of effectively controlling the release of at least one selected from among mirabegron and a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to a pharmaceutical preparation containing an active ingredient and a release-controlling agent for adjusting the release of the active ingredient, in which the active ingredient is at least one selected from among mirabegron and a pharmaceutically acceptable salt thereof, and the release-controlling agent is a hydrogel-forming polymer, the hydrogel-forming polymer being at least one selected from among polyethylene oxide, hydroxypropyl methyl cellulose, hydroxypropyl cellulose, sodium carboxymethylcellulose, and hydroxyethyl cellulose and having an average molecular weight ranging from 100,000 to 8,000,000. The present invention is capable of suppressing the generation of impurities therein and of effectively controlling the release of at least one selected from among mirabegron and a pharmaceutically acceptable salt thereof.

Abstract: Provided is a computer-implemented method, including inputting to a trained machine learning classifier genomic information of a non-training subject that includes features from a tumor sample, wherein the trained machine learning classifier trained on features of tumor samples obtained from training subjects and their a responsiveness to checkpoint inhibition treatment and the machine-learning classifier is trained to predict responsiveness to the treatment, and generating a checkpoint inhibition responsiveness classification predictive of the subject's responding to the checkpoint inhibition with the trained machine-learning classifier, and reporting the checkpoint inhibition responsiveness classification using a graphical user interface. Also provided are a computer system for performing the method and a machine learning classifier trained by the method.

Abstract: The present disclosure discloses a method for reducing ringing artifacts in an X-ray image, comprising: acquiring an X-ray image by scanning an object, wherein the X-ray image comprises grid line artifacts; applying a first bandwidth filter and a second bandwidth filter respectively to the X-ray image so as to obtain a filtered first image and a filtered second image, wherein the first bandwidth filter and the second bandwidth have different bandwidths; constructing a weighting map according to the X-ray image; and fusing the filtered first image and the filtered second image with the weighting map so as to obtain an output image. The present disclosure also discloses a system using the above method.

Abstract: A method for reducing grid line artifacts in an X-ray image is disclosed, which includes acquiring an X-ray image by scanning an object, wherein the X-ray image comprises grid line artifacts; decomposing the X-ray image into a high frequency image and a low frequency image, wherein the high frequency image comprises the grid line artifacts; filtering the high frequency image to reduce the grid line artifacts in the high frequency image so as to obtain a filtered high frequency image; and combining the filtered high frequency image with the low frequency image to reconstruct an output image. A system adopting the above method is also disclosed.

Abstract: The present disclosure discloses a method for reducing ringing artifacts in an X-ray image, comprising: acquiring an X-ray image by scanning an object, wherein the X-ray image comprises grid line artifacts; applying a first bandwidth filter and a second bandwidth filter respectively to the X-ray image so as to obtain a filtered first image and a filtered second image, wherein the first bandwidth filter and the second bandwidth have different bandwidths; constructing a weighting map according to the X-ray image; and fusing the filtered first image and the filtered second image with the weighting map so as to obtain an output image. The present disclosure also discloses a system using the above method.

Abstract: The present invention provides a pharmaceutical composition including an ionic liquid composed of a triptan compound and saccharin. Since a triptan compound and saccharin form an ionic liquid to increase the solubility of the triptan compound in the present invention, it is possible to expect a rapid and high dissolution of the triptan compound when a pharmaceutical composition is prepared. In addition, large amounts of organic solvents and acidic solvents need not be used in order to dissolve the triptan compound.

Abstract: A method for reducing grid line artifacts in an X-ray image is disclosed, which includes acquiring an X-ray image by scanning an object, wherein the X-ray image comprises grid line artifacts; decomposing the X-ray image into a high frequency image and a low frequency image, wherein the high frequency image comprises the grid line artifacts; filtering the high frequency image to reduce the grid line artifacts in the high frequency image so as to obtain a filtered high frequency image; and combining the filtered high frequency image with the low frequency image to reconstruct an output image. A system adopting the above method is also disclosed.

Abstract: An exercise assembly includes a sleeve that has a top end, a bottom end and a peripheral wall extending therebetween. The top end and the bottom end are open. The sleeve may be worn on an appendage of a user. A plurality of pockets is coupled to an outer surface of the peripheral wall. Each of the pockets has an upper end and a lower end. Each of the upper ends is open. A plurality of rods has a first end, a second end and an outer wall extending therebetween. The outer wall has a back side and front side. Each of the upper ends of the pockets insertably receives one of the rods such that the back side abuts the peripheral wall of the sleeve.

Abstract: The present invention provides a pharmaceutical composition including an ionic liquid composed of a triptan compound and saccharin. Since a triptan compound and saccharin form an ionic liquid to increase the solubility of the triptan compound in the present invention, it is possible to expect a rapid and high dissolution of the triptan compound when a pharmaceutical composition is prepared. In addition, large amounts of organic solvents and acidic solvents need not be used in order to dissolve the triptan compound.